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Infertility affects one in seven couples globally and has recently been classified as a disease by the World Health
Organisation (WHO). While in-vitro fertilisation (IVF) offers effective treatment for many infertile couples, cases
exhibiting severe male infertility (19–57%) often remain difficult, if not impossible to treat. In such cases,
intracytoplasmic sperm injection (ICSI), a technique in which a single sperm is microinjected into the oocyte, is
implemented. However, 1–5% of ICSI cycles still fail to fertilise, affecting over 1000 couples per year in the UK alone.
Pregnancy and delivery rates for IVF and ICSI rarely exceed 30% and 23% respectively. It is therefore imperative that
Assisted Reproductive Technology (ART) protocols are constantly modified by associated research programmes, in
order to provide patients with the best chances of conception. Prior to fertilisation, mature oocytes are arrested in
the metaphase stage of the second meiotic division (MII), which must be alleviated to allow the cell cycle, and
subsequent embryogenesis, to proceed. Alleviation occurs through a series of concurrent events, collectively
termed ‘oocyte activation’. In mammals, oocytes are activated by a series of intracellular calcium (Ca2+) oscillations
following gamete fusion. Recent evidence implicates a sperm-specific phospholipase C, PLCzeta (PLCζ), introduced
into the oocyte following membrane fusion as the factor responsible. This review summarises our current
understanding of oocyte activation failure in human males, and describes recent advances in our knowledge linking
certain cases of male infertility with defects in PLCζ expression and activity. Systematic literature searches were
performed using PubMed and the ISI-Web of Knowledge. Databases compiled by the United Nations and World
Health Organisation databases (UNWHO), and the Human Fertilization and Embryology Authority (HFEA) were also
scrutinised. It is clear that PLCζ plays a fundamental role in the activation of mammalian oocytes, and that genetic,
molecular, or biochemical perturbation of this key enzyme is strongly linked to human infertility where oocyte
activation is deficient. Consequently, there is significant scope for our understanding of PLCζ to be translated to the
ART clinic, both as a novel therapeutic agent with which to rescue oocyte activation deficiency (OAD), or as a
prognostic/diagnostic biomarker of oocyte activation ability in target sperm samples.
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Infertility affects one in seven couples globally [1-3], a
worrying statistic which has led to the classification of in-
fertility as a recognised disease by the World Health Or-
ganisation (WHO; [4]). In the UK, 1.5% of all births are the
result of assisted reproductive technology (ART) [5]. In
some other developed countries, this figure can reach 7%
[3,6]. However, while conventional in-vitro fertilisation
(IVF) provides effective treatment for many infertile cou-
ples, several conditions, including severe male infertility
(accounting for 19–57% of cases), remain untreatable with
a normal IVF cycle [7]. In such cases, intracytoplasmic
sperm injection (ICSI), a more sophisticated technique in
which an individual sperm is injected directly into the
oocyte [8], is implemented and has been shown to be an
effective approach for many cases. Despite this revolution-
ary approach, it is estimated that 1–5% of ICSI cycles still
fail [6,9]. Considering that approximately 52% of all IVF
cycles in the UK involve ICSI [5], this represents a signifi-
cant problem, and on average would affect over 1000 cou-
ples per year in the UK alone. Indeed, despite the global
expansion of ART, pregnancy and delivery rates following
IVF and ICSI protocols rarely exceed 32% and 33%, re-
spectively [10]. Consequently, there is constant need for a
greater understanding of the molecular and physiological
mechanisms underlying infertility, such as ICSI failure and
other idiopathic conditions, such that the ART protocols
can be improved, refined, or replaced. It is the intention of
this review to discuss how investigative research into the
process of oocyte activation has led to significant potential
to both enhance existing ART protocols and provide the
possibility of novel diagnostic tests for certain types of
male factor infertility.Oocyte activation
IPrior to fertilisation, mature oocytes remain arrested in
the metaphase stage of the second meiotic division (MII)
[11]. Arrest is maintained by stabilisation of M-Phase pro-
moting factor (MPF), the universal driver for G2/M cell
cycle transition. MPF is a heterodimer consisting of a
regulatory cyclin subunit, cyclin B, and a catalytic subunit,
Cdc2 kinase. Active Cdc2 drives entry into M-phase by
phosphorylating substrates leading to nuclear envelope
breakdown and spindle formation [12]. Upon fusion with a
sperm, MII arrest is alleviated, thereby allowing cell cycle
progression, cell division, and embryogenesis to proceed.
Release of meiotic arrest occurs via a series of concurrent
events, collectively termed ‘oocyte activation’, which con-
vert the oocyte into a totipotent zygote, able to form all
types of body cells [3,13]. These morphological and bio-
chemical events include cortical granule (CG) exocytosis
to prevent polyspermy, extrusion of the second polar body,
maternal RNA recruitment, male and female pro-nuclear(PN) formation, and the initiation of embryonic gene
expression [14-20].
Early research utilised calcium (Ca2+) sensitive dyes to
demonstrate that non-mammalian oocytes, such as those
from sea urchins and frogs, were activated by a single
cytosolic Ca2+ transient initiating from the point of
sperm entry and traversing across the egg to the opposite
pole. In contrast, mammalian oocytes exhibit a series of
Ca2+ ‘oscillations’ (Figure 1) [12,14,15,21-23]. These
changes in cytosolic Ca2+ are now thought to be the uni-
versal trigger for oocyte activation and development
[14,19,24]. Indeed, microinjection of Ca2+ ions alone trig-
gered embryo development to the blastocyst stage in mice
[23,25]. However, the nature, amplitude, duration, and fre-
quency of this vital signal are species- specific [15-17,26].
In mammalian oocytes, Ca2+ oscillations are now gener-
ally accepted to be the direct result of inositol trisphosphate
(IP3)-mediated Ca
2+ release from intracellular Ca2+ stores
Isuch as the endoplasmic reticulum (ER) [23,27-38].
Blocking, down-regulating, or reducing the expression
levels of IP3 receptors (IP3Rs) in mouse and hamster
oocytes, all inhibit Ca2+ oscillations and thus oocyte acti-
vation [39-42]. Furthermore, cytosolic increases in IP3
concentration during fertilisation in mammalian oocytes
[23] provided further support for the importance of IP3
levels and IP3-mediated Ca
2+ release.
Oocytes are remarkably sensitive to the specific frequency
and amplitude of the Ca2+ oscillations evoked. The initial
increase in intracellular Ca2+ appears to be critical for the
initiation of both early and late events of oocyte activation
[14,17,43], as well as exerting peri-implantation effects
upon gene expression and development to term [17,44-46].
Many early activation events of physiological importance
are not simultaneously initiated following the initial Ca2+
transient, but occur in a temporal order [17,45] through
spatial and temporal regulation of periodic Ca2+ release
[47]. The frequency and amplitude of Ca2+ oscillations in-
fluence cell cycle progression rates and protein expression
profiles in early mouse embryos [16], and embryonic devel-
opment in rabbits [19,48]. Considering that the rate of pro-
gression to the 2- and 4-cell stages of human oocytes
following fertilisation has been proposed as an indicator of
normal embryogenesis [49], the profile of Ca2+ oscillations
at fertilisation may not only be necessary for oocyte ac-
tivation, but may also be equally important for subse-
quent embryogenesis. Indeed, alterations in the Ca2+
oscillatory activity of vitrified mouse oocytes were found
to directly affect oocyte quality and subsequent embry-
onic development [50].
Many theories have attempted to explain how the ferti-
lising sperm elicits Ca2+ oscillations following mammalian
gamete fusion [24,32,33,35,51]. One such model relates
the interaction of the sperm with a coupled receptor on
the plasma membrane of the oocyte, which in turn
Figure 1 A) Calcium wave as observed using calcium-green-1-dextran in a Xenopus egg. Time 0 shows the egg’s resting levels of calcium.
The sperm-induced calcium wave was initiated by sperm entry (indicated by white arrow), and traversed the entire egg. B) Ca2+ responses at
fertilisation in eggs and oocytes of several species. C) Ca2+ release profile observed during human fertilisation. Reproduced from Fontanilla and
Nuccitelli (1998) and Miyazaki (2006) with permission. Figure 1C reproduced from Rogers et al. (© Society for Reproduction and Fertility, 2004),
with permission.
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linked cascade or via tyrosine kinase activity. Indeed, this
‘membrane/receptor’ model was the dominant theory for
many years [35,52]. However, despite many targeted stud-
ies, a sperm ligand/oocyte receptor of this nature still
remains to be characterised [35]. Critically, the successful
nature of microinjection techniques such as ICSI casts sig-
nificant doubt over the membrane receptor theory as thistechnique bypasses sperm/oocyte membrane interaction
completely.
A second model proposed that a soluble oocyte activa-
tion factor is released into the oocyte following gamete
fusion, and subsequently interacts with ooplasmic com-
ponents, ultimately leading to Ca2+ release. Indeed, the
injection of sperm extracts into the oocytes of a variety
of species, including marine worms, and ascidians,
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[15,53,54]. Sperm extracts from frogs, chickens, and
tilapia fish, also trigger Ca2+ oscillations in mouse oocytes
[55-57], suggesting the existence of a similar sperm-based
mechanism throughout a wide spectra of species. A consid-
erable body of research suggested that the IP3-dependant
nature of oocyte activation depended upon a phospholipase
C (PLC)-mediated mechanism [35], suggesting that the
oocyte activation factor was a sperm-based PLC [26,48,58].
This supported the notion that the soluble sperm factor
was a PLC which mediated the hydrolysis of phosphotidyli-
nositol 4,5-bisphosphate (PIP2) to IP3 and diacylglycerol
(DAG), leading to the activation of signalling pathways
mediated by protein kinases, such as protein kinase C
(PKC) [23,39,59]. General consensus agreed that the soluble
factor responsible for Ca2+ release within oocytes was
sperm-specific, as extracts from other tissues did not result
in Ca2+ induction upon oocyte injection [53,60]. However,
the specific identity of such a PLC isozyme remained a
mystery for some time.
PLCζ as the putative oocyte activation factor
Using mouse express sequence tag (EST) databases,
Saunders et al. (2002) successfully identified a novel
testis-specific PLC, termed PLCzeta (PLCζ), a ~74 kDa
protein which was proven to play a key role in oocyte
activation [59]. Subsequent studies have identified fur-
ther mammalian PLCζ orthologues in human, hamster,
monkey, and horse sperm [59,61-65], as well as in non-
mammals such as chicken, fish, and quail [57,66-68].
Numerous studies support the contention that PLCζ is
the physiological agent responsible for IP3-mediated Ca
2+
release in activating oocytes (Figure 2) [18,59,61]. Micro-
injection of both PLCζ cRNA and recombinant protein
into mouse and bovine oocytes resulted in the initiation of
oscillations and oocyte activation, similar to that seen dur-
ing normal fertilisation, and stimulated embryonic develop-
ment to the blastocyst stage [59,61,69-74]. Injection of
human PLCζ cRNA also initiated Ca2+ oscillations in
human oocytes and led to pre-implantation development
[75]. Depletion of PLCζ from sperm extracts [59], or the
inhibition of PLCζ expression in sperm using transgenic
RNA interference [76], significantly abolished the ability to
initiate Ca2+ release, or caused premature termination of
Ca2+ oscillations and reduction in litter size.
Interestingly however, Coward et al. (2011) recently
identified ovarian and brain isoforms of PLCζ in puffer-fish
(Takifugu rubripes) [68]. Injection of cRNA corresponding
to the ovarian isoform into mouse oocytes did not induce
Ca2+ oscillations [68]. It is possible that puffer-fish PLCζ
requires further oocyte- or sperm-based factors for Ca2+
inducing activity. Intriguingly, expression of puffer-fish
PLCζ was also observed within the brain. This was particu-
larly surprising considering that PLCζ is generally reportedto be testis-specific [68]. While, Yoshida et al. (2007)
reported the expression of PLCζ mRNA in the brain of
both male and female mice [77], this directly contradicted
the findings of Saunders et al. (2002) [59]. While it would
be of interest to investigate the physiological relevance of
PLCζ isoforms in the brain, it would first be necessary to
confirm these earlier findings using more rigorous method-
ology [68].
Although it is possible that the ovarian PLCζ isoform in
puffer-fish is an evolutionary adaption related to repro-
ductive strategy, this discovery was particularly interesting
given the debate regarding the mechanism responsible for
oocyte activation [19,35,68,78]. Recent studies have pro-
posed alternative sperm factor candidates apart from
PLCζ, which are able to induce meiotic progression or the
typical pattern of Ca2+ oscillations in a variety of species.
Sette et al. (1997) previously identified the truncated c-kit
(tr-kit), enriched in mouse sperm, as being an oocyte acti-
vation factor demonstrating meiotic resumption and
mouse oocyte activation on microinjection of extracts
expressing recombinant tr-kit [79]. Harada et al. (2007)
identified citrate synthase as the major component re-
sponsible for egg activation in the newt Cynops pyrrhoga-
ster [80], however, citrate synthase is not a proposed
oocyte activation factor in mammals. Wu et al. (2007) also
reported another possible candidate for the sperm factor,
residing in the post-acrosomal sheath region of the peri-
nuclear theca, termed post-acrosomal sheath WW do-
main-binding protein (PAWP), in bovine sperm and other
mammalian species [81]. Despite PAWP and citrate syn-
thase representing alternative candidates to PLCζ as the
oocyte activation factor, the precise molecular mechan-
isms underlying the function of both proteins remain un-
known, with no demonstration of the proteins triggering
Ca2+ oscillations in mammalian oocytes casting doubt
over their candidacy of being the mammalian oocyte acti-
vation factor [82]. While it is possible that oocyte activa-
tion involves the collective action of PLCζ and other
sperm factors, such theories remain to be established [3].
Furthermore, it is also possible that oocyte-borne factors,
similar to puffer-fish PLCζ, may contribute towards the
activation mechanism.
Current data provides evidence that PLCζ represents a
factor that is crucial to the process of mammalian oocyte
activation. Consequently, this protein has been the target
of a series of molecular and biochemical studies over re-
cent years. PLCζ exhibits a typical PLC domain structure
[59] with characteristic X and Y catalytic domains which
form the active site in all PLC isoforms (β, γ, δ, E and η)
[83-85], a single C2 domain and four tandem EF hand
domains. PLCζ exhibits closest homology with PLCδ,
with 33% similarity [59]. However, one major difference
to other PLCs is the absence of pleckstrin homology
(PH) and Src homology (SH) domains, making PLCζ the
Figure 2 Schematic representation of the current understanding of PLCζ mechanism of action. Following sperm/oocyte fusion, PLCζ is
released into the cytoplasm of the oocyte, where it facilitates the hydrolysis of membrane-bound PIP2 to DAG and IP3, triggering Ca
2+ release from
intracellular Ca2+ stores, leading to Ca2+ induced Ca2+ release and oocyte activation. The schematic illustrates the previous theory of PLCζ action upon
membrane-bound PIP2, which is now being considered to be organelle-bound. N: Nucleus; PIP2: Phosphotidylinositol 4,5-bisphosphate; IP3: inositol
trisphosphate; DAG: diacylglycerol; PKC: Protein kinase C; ER: Endoplasmic reticulum.
Ramadan et al. Cell Communication and Signaling 2012, 10:12 Page 5 of 20
http://www.biosignaling.com/content/10/1/12smallest known mammalian PLC with a molecular mass
of ~70 kDa in humans and ~74 kDa in mice (Figure 3)
[59]. Another distinctive feature of PLCζ is its high sensi-
tivity to Ca2+ [69]. The catalytic XY domain is highly con-
served, showing close homology with PLCδ, and
mutagenesis of active site residues leads to total loss of
Ca2+-oscillatory ability [33,86-88]. However, the X-Y linker
region is poorly conserved amongst PLCζ isoforms, except
for the presence of positively charged amino acids,
prompting speculation that differing motifs in this region
may underlie species-specific patterns of Ca2+ oscillations
amongst mammals [33,36,89]. Nomikos et al. (2011) re-
cently suggested that these charged amino acids may play
an important role in the interaction of PLCζ with PIP2
[87,90,91]. Yu et al. (2011) further demonstrated thatFigure 3 Schematic representation of PLCζ domain distribution.whilst PLCδ targets PIP2 at the oolemma, mouse PLCζ
appeared to target intracellular membranous PIP2 on dis-
tinct vesicular structures within the mouse oocyte cortex
[92]. Moreover, fluorescently-tagged human recombinant
PLCζ indicated localisation to discrete regions within the
cell cytoplasm when expressed in HEK293T cells, adjacent
to the nuclear envelope, possibly representing a specific
organelle sub-type [74]. In accordance with these findings,
mouse PLCζ remains in an inactive state and fails to in-
duce Ca2+ oscillations in the CHO cell line, which are
known to be devoid of organelle-bound PIP2 [93].
As well as providing evidence for the Ca2+ releasing tar-
get of PLCζ, this also suggests that specific factors within
the ooplasm may be required for PLCζ-mediated Ca2+ re-
lease [93]. However, Kashir et al. (2011a) demonstrated that
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within HEK293Tcells, and maintained activity following in-
jection of transfected HEK293T lysates into mouse oocytes
[74]. Furthermore, there was a clear delay between lysate
injection and the initiation of Ca2+ oscillations, possibly in-
dicating that oocyte-based mechanisms resulted in the
modification of recombinant PLCζ, ultimately resulting in
an active state [74]. It is possible that these differences are
due to inter-species variance, or the type of mammalian
cells deployed in laboratory-based experiments. Indeed,
human PLCζ has been shown to be much more potent in
terms of PLC activity compared to the mouse isoform
[3,33,35,59,61,71]. It also remains possible that HEK293T
cells contain molecular mechanisms not present within
CHO cells, which ultimately led to the presence of active
PLCζ. Collectively, these studies provide significant insight
into the mechanism of action of PLCζ, and demonstrate
the importance of continued research effort, particularly
with regard to the activation of human oocytes.
A sequence of amino acids predicting a nuclear localisa-
tion signal (NLS) was identified in the X-Y linker region of
mouse PLCζ, thought to be a binding site of the nuclear
transport receptor, which may play a role in regulating
PLC activity. The distribution of PLCζ within the activat-
ing mouse oocyte changes during the first cell cycle, exhi-
biting PN localisation during zygotic interphase [66,94-97]
thereby restricting access of the enzyme to its substrate
PIP2, and thus resulting in termination of Ca
2+ oscilla-
tions. Mutation of this putative NLS sequence prevented
nuclear accumulation, as well as the termination of oscil-
lations at interphase [33,95]. Kuroda et al. (2006) hypothe-
sised that PLCζ is driven into the nucleus primarily by the
NLS [98]. Close contact with EF/C2 domains appears to
be required not only for enzymatic activity but also for nu-
clear translocation ability [69,96,99,100].
However, the injection of human, bovine, rat or medaka
fish PLCζ into mouse oocytes does not result in PN trans-
location [64,66,97]. It is not yet clear whether human PLCζ
has a distinctive NLS sequence, although nuclear localisa-
tion may prove to be the result of a conformational change
or modification arising from interaction with other, as yet
unknown, adaptors. It is worth noting that Ito et al. (2008)
demonstrated nuclear localisation of human and mouse
PLCζ in COS-7 cells, and that Coward et al. (2006)
observed localisation of mouse PLCζ to either the nucleus
or cytoplasm of COS cells [101]. In a more recent study,
Kashir et al. (2011a) detected cytoplasmic localisation of
human PLCζ when expressed in HEK293T cells [74]. While
there seems to be conflicting evidence in this regard, the
observed lack of nuclear localisation could reflect either the
cell type used, or the reduced nuclear localisation activity of
human PLCζ compared to mouse. It may also be the case
that functional disparities may exist between the mouse
NLS, as well as any potential human NLS. However, theexistence, and functional significance if any, of the human
PLCζ NLS must be confirmed before any such comparison
can be made.
Upon PN envelope breakdown during entry into mi-
tosis, Ca2+ oscillations resume [11,94-96,102] and may act
in conjunction with modifications to the IP3 receptor to
terminate Ca2+ signals at fertilisation [31,95]. Sone et al.
(2005) showed that this pattern of PLCζ expression con-
tinues beyond first mitosis by exogenously expressing
PLCζ at later stages of embryo development, showing con-
tinued nuclear sequestration of PLCζ during mitotic pro-
liferation [103]. Thus, shuttling of PLCζ between the
cytoplasm and nucleus appears to be strongly related to
the termination/resumption of Ca2+ oscillations in a cell-
cycle dependent manner, suggesting a possible role for
PLCζ in mediating the cell-cycle dependency of Ca2+
oscillations in the early embryo [103]. Since no other spe-
cies share the ability of mouse PLCζs for nuclear trans-
location, it remains unclear whether this is a widespread
phenomenon in mammals, or whether it holds any
physiological importance.
PLCζ is thought to remain in an inert state within
sperm, and once introduced into the oocyte by gamete
membrane fusion, becomes enzymatically active [33]. It
is currently unclear how such a physiologically active
protein is maintained in an inert form within sperm.
Studies indicate that there may be an oocyte component
that is necessary for the activation process [74,77,93].
Elucidation of what the oocyte factors are may explain
how PLCζ is maintained in an inactive state in the sperm
but is activated on release into the oocyte. It is possible
that PLCζ needs to undergo post-translational modifica-
tions before reaching an active state [64]. Indeed, spon-
taneous proteolysis of PLCζ was apparent in both mouse
and porcine sperm [89,104], with cleaved products re-as-
sociating to form functional heterodimers with increased
levels of activity [89]. Moreover, a 62 kDa PLCζ isoform
lacking EF1-3 hand domains was previously described in
mouse sperm [69,89,99,104,105], and reported to acti-
vate mouse oocytes and support normal development to
term [100]. Intriguingly, purified recombinant mouse
PLCζ did not undergo cleavage, retained activity in-vitro,
but was far less efficient at inducing Ca2+ oscillations in
mouse oocytes [69,99,105]. It is vital, therefore, that fu-
ture studies elucidate whether post-translational or cova-
lent modifications such as cleavage are a necessary
requirement for endogenous PLCζ activity.
There appears to be significant species-specific differ-
ences in the concentration and activity of PLCζ delivered
into oocytes during fertilisation, allowing for the different
specific requirements of each species, and the specific Ca2+
oscillation pattern leading to embryo development [64].
PLCζ has been detected in sperm from many species, and
is localised to distinct regions in the sperm head, with
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tion [3,63,106]. Three distinct populations of PLCζ have
been identified in the human sperm head; acrosomal, equa-
torial and post-acrosomal [85,106,107], whereas in mouse
and boar sperm, two populations have been identified –
acrosomal and post-acrosomal [63,108,109]. In equine
sperm, PLCζ was reported to be localised to the acrosome,
equatorial segment and head mid-piece, as well as principle
piece of the flagellum [65]. In the pig, PLCζ was identified
in the post-acrosomal region, and the tail [110].
Young et al. (2009) demonstrated dynamic changes of
PLCζ localisation in mouse sperm following capacitation
and the acrosome reaction [63]. Prior to capacitation,
both populations were present, with the acrosomal
population being more prominent, and following capaci-
tation, sperm showed post-acrosomal localisation only.
Grasa et al. (2008) echoed the findings of Young et al.
(2009) in capacitated and non-capacitated fertile human
sperm, but described three distinct populations of PLCζ
suggesting differential roles for each population [106]
(Figure 4). Furthermore, Bi et al. (2009) identified an
isoform of PLCζ, which they inexplicably termed NYD-
SP27, found in the acrosome of human and mouse
sperm [111]. These authors suggested that this protein
was necessary for capacitation and the acrosome reac-
tion, functioning as an intrinsic decapacitation factor.
However, further evidence of this intriguing possibility
has yet to be forthcoming.
Grasa et al. (2008) indicated that PLCζ was predomin-
antly localised to the equatorial region of human sperm,
with relatively smaller populations in the acrosomal and
post-acrosomal regions [106]. While it is not yet clear
whether a particular pattern of localisation is required, ora
b
Figure 4 Immunofluorescent localisation of PLCζ (red) in
(A) hamster and (B) human sperm. Fluorescein
isothiocyanate-conjugated peanut agglutinin (FITC-PNA)-lectin
staining (green) identifies the acrosome, and Hoescht-33342 staining
(blue) identifies the nuclei. Arrows indicate the immunolocalisation
of PLCζ within the acrosome and equatorial segment of hamster
and equatorial segment of human sperm. DIC: differential
interference contrast. Reproduced from Young et al. (2008) and
Grasa et al. (2008) with permission.whether a combination of different populations is required
for functional ability, the equatorial and post-acrosomal
populations would indeed permit rapid access to the
ooplasm following sperm-oocyte fusion [112-114]. Indeed,
post-acrosomal populations of PLCζ have also been identi-
fied in mouse, hamster, bull, pig, and boar sperm
[63,102,106,108-110]. Furthermore, the presence of the
post-acrosomal population of PLCζ following in-vivo
induced acrosome reaction provides further credence to a
specific role for this protein in oocyte activation, as the fac-
tor responsible would be expected to be retained following
this important physiological process [63,106].
It has yet to be confirmed as to whether the population
of PLCζ in the acrosomal region of sperm plays a role in
the acrosome reaction as some studies suggest [63,106,111].
Aghajanpour et al. (2011) suggest that the localisation of
PLCζ to the acrosome may be independent of PLCζ mRNA
expression, suggesting that the observed reduction in ex-
pression of PLCζ mRNA in globozoospermic sperm may
be related to other factors and not absence of the acrosome
[115]. While it is possible that the acrosomal population
plays a role in fertilisation, questions regarding the timing
of the acrosome reaction relative to sperm-oocyte fusion
[116] indicate that further work is required before such
assertions are made. Understanding the relative roles of dif-
ferential populations of PLCζ will be essential prior to the
use of this protein clinically, and should thus be the focus
of future research directives. However, it is important to
note that the polyclonal nature of all PLCζ antibodies used
thus far may explain the variance in localisation patterns
observed between existing studies. Indeed, Aarabi et al.
(2012) recently suggested PLCζ localisation to only the
acrosomal and post-acrosomal regions of mouse, boar, and
human sperm [117]. While the specificity of this particular
antibody was previously confirmed by Grasa et al. (2008) in
human sperm [106], immunoblotting results from the study
by Aarabi et al. (2012) also appeared to identify cross-
reactivity with unidentified proteins other than PLCζ [117].
Furthermore, considering that Grasa et al. (2008) suggested
variance in predominant localisation patterns amongst fer-
tile males (sperm from 6 human males), specific conclu-
sions cannot be drawn from the relatively smaller sample
size (sperm from 3 human males and 1 mouse) examined
by Aarabi et al. (2012). However, it is imperative that efforts
are directed towards the synthesis of more specific mono-
clonal antibodies against PLCζ before conclusive remarks
regarding variant isoforms and localisation patterns of PLCζ
may be made.
PLCζ mRNA expression and the initiation of transla-
tion have been identified during early and late stages of
spermatogenesis in mice and pigs [62,63,65,109,118].
PLCζ mRNA has also been identified in ejaculated
human sperm [115,119-121]. While injection of PLCζ
cRNA into the oocyte induces the production of PLCζ
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zygote remains to be ascertained. Considering there is a
considerable difference in sperm mRNA content between
fertile and infertile individuals [122], it seems plausible to
consider that similar differences may apply to PLCζ, with
consequential repercussions on fertility.
Links between PLCζ and male-factor infertility
Deficiency in the mechanism of oocyte activation is
regarded as the principal cause of fertilisation failure
following ICSI, accounting for an estimated 40% of failed
cases [3,123-125]. However, ICSI addresses only one of the
necessary requisites for successful fertilisation, that of
sperm penetration, whereas a range of post-penetration
events are crucial for successful fertilisation [126]. The aeti-
ology of ICSI failure in such cases is likely to be multi-
factorial in nature, and may be attributable to factors in the
oocyte since the inherent quality of the oocyte is of great
importance for successful fertilisation. Such factors would
thus be reliant upon the fidelity of oocyte maturation, such
as the inadequate sensitisation of IP3 receptors and ER
Ca2+ concentration regulation required for optimal sperm-
initiated Ca2+ release [11,127-129], or a reduction in the
number of CG due to premature release, resulting in early
blockade to polyspermy prior to insemination [20,130]. The
suggestion that oocyte quality plays a role in fertility is fur-
ther strengthened by a recent study reporting that the
process of vitrification in ART affects the distribution of
IP3Rs, with subsequent detrimental effects upon Ca
2+ oscil-
latory activity and embryo development, thus providing an
explanation for low rates of blastocyst formation following
ICSI treatment using vitrified oocytes compared to fresh
oocytes [50].
Sperm defects however, are considered the leading
cause of activation failure [3], and given the role of PLCζ
as the oocyte activating factor; it is highly plausible that
defective forms, or abnormal function, of PLCζ may be
the underlying cause of certain types of male-factor in-
fertility and oocyte activation failure. Indeed, evidence
indicates that the severity of sperm defects, opposed to
sperm source, determines the efficacy of ICSI success
[131]. Much evidence now exists to highlight PLCζ’s role
in fertility and relative role in male-factor infertility.
Sperm from infertile men which consistently fail IVF
and ICSI, also fail to induce Ca2+ oscillations upon injec-
tion into mouse oocytes, or cause abnormal patterns of
Ca2+ release when compared with those of fertile males
[86,107] (Figure 5A). Such sperm also exhibited absent/
reduced levels, or abnormal isoforms, of PLCζ (Figure 5B)
[86,107].
The first genetic link between PLCζ and oocyte activa-
tion deficiency (OAD) was reported by Heytens et al.
(2009), who identified a substitution mutation in an in-
fertile male diagnosed with OAD [86]. This involved asubstitution of a histidine to proline within the Y do-
main of the catalytic site of the protein, at position 398
of the PLCζ open reading frame (PLCζH398P). Micro-in-
jection of PLCζH398P cRNA into mouse oocytes failed to
induce Ca2+ oscillations, whilst the injection of sperm
possessing this mutation resulted in an atypical pattern
of Ca2+ oscillations [86]. An equivalent mutation was
subsequently created for mouse PLCζ (PLCζH435P) [88];
murine experiments confirmed that this mutation
caused major structural changes to the PLCζ protein,
resulting in functional inactivation.
More recently, Kashir et al. (2012) identified a further
novel point mutation from the same patient from whom
the H398P mutation was first identified, involving a sub-
stitution of a histidine to leucine residue in the catalytic X
domain at position 233 of the PLCζ open reading frame
(PLCζH233L) [132]. Micro-injection of PLCζH233L cRNA
resulted in an abnormal Ca2+ release profile and like the
H398P mutation, a failure to activate oocytes (Figure 6)
[132]. Interestingly, this study also showed that both the
PLCζH398P and PLCζH233L mutations, which are heterozy-
gous in nature, originated from different parental origins:
PLCζH398P was paternal in origin, while PLCζH233L was
maternal. These findings represented the first description
of an autosomal point mutation resulting in male fertility
via the maternal lineage [132]. Furthermore, albeit specu-
lation at present, Kashir et al. (2012) hypothesised that
mutations in PLCζ may be recessive in nature, requiring
mutation on both parental alleles for full infertility to
occur. One would also reason that heterozygous muta-
tions in PLCζ may result in cases of sub-fertility. Indeed,
Kashir et al. (2011a) reported that HEK293T cells over-
expressing fluorescently-tagged PLCζH398P exhibited a
lower level of fluorescence compared to HEK293T cells
over-expressing fluorescent-PLCζWT, correlating to ab-
sent/severely reduced levels of PLCζ in sperm from the
patient from whom the H233L and H398P mutations
were identified [74].
Furthermore, absent/reduced levels of PLCζ in sperm
have been implicated in forms of male infertility where
such sperm is repeatedly unable to activate oocytes
[86,107,133]. It is therefore possible that cases in which
PLCζ is absent or severely reduced may be due to desta-
bilising effects caused by mutation in highly conserved
regions of PLCζ. However, studies examining the role of
deletions in critical domains essential to mouse PLCζ
function did not report any differences in protein stabil-
ity [89,105]. Furthermore, considering that sperm and
HEK293T cells may exhibit very different molecular
mechanisms, it is important that future studies examine
the effect of mutant PLCζ in testicular germ cells to
investigate whether such a trend is repeated, and to de-
termine whether such loss-of-activity mutations are
potentially disruptive to the overall folding of PLCζ.
iii
PL Acrosome Nucleus DIC/Overlay
a
b
Figure 5 A) Ca2+ oscillation profiles following the injection of sperm from normal fertile humans (top panel) and infertile patients who
had previously failed or exhibited low fertilisation rates following ICSI (bottom panel). Arrows denote time of sperm injection, and n
indicates the number of mouse oocytes exhibiting the corresponding Ca2+ oscillation profile. B) Reduced PLCζ immunostaining (red) in sperm
from infertile ICSI failed patients exhibiting abnormal morphology (in this case globozoospermia; acrosome-less, round-headed sperm) (i), and
normal morphology (ii). Fluorescein isothiocyanate-conjugated peanut agglutinin (FITC-PNA)-lectin staining (green) identifies the acrosome, and
Hoescht-33342 staining (blue) identifies the nuclei. Arrow indicates reduced PLCζ immunolocalisation within the equatorial segment. Scale bars
indicate 5 μm. Reproduced from Yoon et al. (2008) and Heytens et al. (2009) with permission.
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Although ICSI results in average fertilisation rates of
70% [3,134], complete or virtually complete fertilisation
failure still occurs in 1–5% of ICSI cycles [3,9,124,135],
corresponding to approximately 1000 cases per year in
the UK alone. The incorrect injection of sperm, expul-
sion of injected sperm from the oocyte, and the failure
of sperm head decondensation are not considered to
contribute substantially to fertilisation failure following
ICSI [3,9]. A deficiency in the mechanism of oocyte acti-
vation is regarded as the principal cause of fertilisation
failure, or abnormally low fertilisation after ICSI, and
can recur in successive ART cycles [3,123,136]. At
present, such cases can only be resolved using assisted
oocyte activation (AOA).
Cases of oocyte activation failure can currently be
treated by AOA methods such as Ca2+-ionophore orstrontium chloride [9,133,136,137]. The most popular arti-
ficial activating agents for human oocytes include Ca2+
ionophores such as ethanol, ionomycin and A23187, elec-
trical pulses, often in combination with protein synthesis
or kinase inhibitors such as 6-dimethylaminopurine (6-
DMAP) or puromycin that block the re-synthesis of cyclin
B or CDK1 activity [136]. Taylor et al. (2010) demonstrated
high rates of fertilisation, and successful pregnancy, in
PLCζ-deficient globozoospermic patients using a Ca2+
ionophore to artificially activate the oocytes following ICSI
[133]. However, there is significant concern as to how such
chemicals may be detrimental to embryo viability and fu-
ture health due to potential cytotoxic, mutagenic and
teratogenic effects on oocytes and embryos [6]. Ca2+ re-
lease patterns following ionophore treatment do not mimic
those observed during normal fertilisation (Figure 7) [86].
Consequently, the abnormal Ca2+ signal induced, which
i ii
i ii




Figure 6 Schematic representations of the effects of the Histidine>Proline (PLCζH398P) (A) and Histidine> Leucine (PLCζH233L) (B) point
mutations identified by Heytens et al. (2009) and Kashir et al. (2012) in an infertile male patient diagnosed with oocyte activation
deficiency. For both A) and B), schematics represent local protein folding before mutation (i) and after mutation (ii). C) Microinjection of wild
type and mutant PLCζ into mouse oocytes and resulting calcium release patterns. FI 340/380: ratio of fluorescence at wavelengths of 340 nm and
380 nm. Reproduced from Heytens et al. (2009) and Kashir et al. (2012) with permission.
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http://www.biosignaling.com/content/10/1/12often manifests as a single Ca2+ transient, is a potential
threat to ensuing development at later stages [45,138], with
potential repercussions on epigenetic processes [139].
Moreover, the threat is increased in cases of AOA with
abnormal sperm such as in cases of globozoospermia, due
to the high degree of sperm DNA fragmentation associated
with this pathology [133,139,140]. Other activating agents
have been shown to induce multiple transients, such as
strontium chloride in mice [14,141], phorbol esters [141]
or thimerosal [142]. These, however, have only been
reported to be efficient in a limited number of species, areless efficient than ionophores in most species, or can cause
meiotic spindle disruption [143].
The most efficient of these is Strontium (Sr2+), which
was found to elicit Ca2+ oscillations through the syner-
gistic action of PLC activation and IP3 activity mediation
via IP3 receptor sensitisation to release Ca
2+ [144], the
use of which resulted in successful pregnancy of normo-
zoospermic patients diagnosed with OAD [145]. How-
ever, Sr2+ treatment varies in terms of oocyte activation
efficacy depending on the species in which it is used [9]
with success rates being relatively low in humans [145].
Figure 7 Representative Ca2+ responses of bovine oocytes treated with A) sperm (normal fertilisation), B) 7% ethanol, and C) Ca2+
ionophore IA23187. Reproduced from Nakada and Mizuno (1998) with permission.
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http://www.biosignaling.com/content/10/1/12Furthermore, little is currently known as to the down-
stream effects of Sr2+ treatment on signalling molecules
such as PKC and DAG. It would, therefore, be prudentto investigate and develop new methods of AOA which
elicit Ca2+ release in an endogenous manner, to circum-
vent these concerns for clinical scenarios. An ideal
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human PLCζ protein, the principle of which has been
previously demonstrated by Yoon et al. (2008) using
mouse cRNA [107].
Yoon et al. (2008) showed that the failure of sperm exhi-
biting abnormal PLCζ localisation to activate an oocyte
could be rescued upon co-injection with mouse PLCζ
mRNA (Figure 8) [107], while Rogers et al. (2004) showed
that it was possible to generate blastocysts parthenogenetic-
ally following the injection of PLCζ cRNA into human
oocytes [75], providing significant support for the clinical
use of PLCζ as a therapeutic. However, the therapeutic util-
isation of PLCζ cRNA is not likely to be viable, since the
uncontrollable transcription of PLCζ may be detrimental to
normal pre-implantational development through gene ex-
pression irregularities, with developmental defects observed
in some embryos [16,45,75]. Moreover, injected PLCζ RNA
could potentially be reverse transcribed into cDNA which
may then be incorporated into the genome [3,146]. It fol-
lows therefore, that an active, purified, recombinant version
of PLCζ would be the ideal alternative for therapeutic appli-
cation in the clinic, as it would function in a safe and
endogenous manner.
Consequently, the synthesis of a pure and active re-
combinant form of PLCζ has been a key goal over recent
years. However, this has proved far more difficult than
first perceived. Purification, in particular, tends to be
tenuous with previous studies culminating in an inactive
protein following purification. This suggests either that
the purification process itself renders the protein in-
active, or that the laboratory processes involved did not
permit key post-translational modifications or protein-
folding mechanisms [64]. Kouchi et al. (2004) success-
fully purified a mouse recombinant PLCζ protein which
exhibited high Ca2+ sensitivity and induced Ca2+ oscilla-
tions upon injection into mouse oocytes [69]. However,
these oscillations were of a much higher frequency than
those seen during normal fertilisation and have proved
difficult to replicate thereafter. More recently, Phillips
et al. (2011) demonstrated that a cell lysate prepared
from CHO cells transfected with mouse PLCζ exhibited
high recombinant protein expression, and on micro-
injection into mouse oocytes, elicited Ca2+ oscillations
representative of oocyte activation [93].
Until very recently, progress remained slow in extrapo-
lating such techniques to the human protein. However,
the use of a human cell line has finally yielded a cell lys-
ate expressing a recombinant human PLCζ protein
which, upon injection into mouse oocytes, elicited Ca2+
oscillations characteristic to those seen in normal fertil-
isation [74]. While representing a significant milestone
in the clinical translation of PLCζ (Figure 9), there is still
much to accomplish, given that activity was only evident
in cell lysates, and not in a purified form.Given that PLCζ plays a fundamental role in the
process of oocyte activation, it is logical to deliberate
how this knowledge might assist with the generation of
a male contraceptive agent for fertile males, for example
by specifically blocking the physiological action of PLCζ.
However, this is not without complication and a signifi-
cant body of research would be required to pursue this
goal, including elucidation of the three-dimensional
structure of the protein. Given that PLCζ has been
detected in tissues and cells other than sperm in non-
mammalian species [68], it would appear prudent to
carry out wider scale expression studies to re-confirm
that PLCζ is specifically expressed in human sperm and
not any other cell or tissue-type. While inactivation of
the PLCζ protein is theoretically possible, it is critical
that new contraceptive agents are safe, reversible, effective,
and specific in their mode of action upon target mechan-
isms. One particular caveat, is the fact that PLCζ RNA has
been identified in ejaculated sperm [115,120,121], suggest-
ing that even if PLCζ protein is inactivated in epididymal
sperm, stocks of RNA remaining in the sperm may be able
to contribute towards Ca2+ release [72,74,75,107]. While
levels of PLCζ RNA present in sperm may not be sufficient
to lead to complete oocyte activation, these levels may con-
tribute towards the overall pattern of Ca2+ release. Indeed,
injection of human PLCζ cRNA as low as 0.001 μg/μl and
0.02 μg/ml are able to result in Ca2+ release in mouse and
human oocytes respectively [61,74].
PLCζ as a prognostic biomarker of male fertility
Semen analysis based on concentration, motility and
morphology has been used for the diagnosis of male fer-
tility for many years, using criteria for normal semen
parameters established by the WHO [147]. However, a
significant number of patients with normal sperm para-
meters still undergo difficulty in achieving successful
pregnancy [148]. This reflects the complexity of the
events involved in sperm function, indicating that ana-
lysis based on concentration, motility and morphology
may not represent an entirely accurate tool to assess the
fertilising potential of a sperm sample. Consequently,
there is significant interest at present for the develop-
ment of additional tests to complement existing analyt-
ical procedures. Recent studies have demonstrated the
potential of measuring sperm nuclear DNA fragmenta-
tion and protamine deficiency in sperm samples by re-
vealing significant differences between fertile and
infertile sperm [149,150].
It is conceivable that the quantitative analysis of PLCζ
within sperm may represent a rapid and informative diag-
nostic tool for both research and clinical purposes, by pro-
viding an indicator, or biomarker, of oocyte activation
ability. A heterologous ICSI model, the mouse oocyte acti-
vation test (MOAT), was previously developed to evaluate
Figure 8 Injection of a sperm from a fertile control elicits Ca2+ oscillations and activates mouse oocytes (top panel). Sperm from an
infertile patient with a history of ICSI failure was unable to elicit Ca2+ oscillations, and was unable to activate mouse oocytes following injection
(middle panel), but was able to do so following the co-injection of PLCζ mRNA (bottom panel). Arrows denote time of sperm injection. 1st PB,
first polar body; 2nd PB, second polar body. TO-PRO-3 staining (blue) stains chromatin. Asterisk in inset points to the persistence of the human
sperm tail in mouse eggs. Scale bar indicates 10 μm. Reproduced from Yoon et al. (2008) with permission.






Figure 9 Representative Ca2+ oscillation profiles of mouse oocytes injected with lysates obtained from HEK293T cells transfected with
PLCζ isoforms. Baseline values for all Ca2+ traces are stacked to facilitate visualization of the responses. Empty vector: Ca2+ trace obtained from
injection of lysates obtained from HEK293T cells transfected with vector without PLCζ; PLCζH398P: Ca2+ trace obtained from injection of lysates
obtained from HEK293T cells transfected with the H398P isoform of PLCζ; PLCζWT: Ca2+ trace obtained from injection of lysates obtained from
HEK293T cells transfected with wild type PLCζ; CHX: cyclohexamide (an inhibitor of RNA synthesis). Figure reproduced from Kashir et al. (2011a)
with permission.
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http://www.biosignaling.com/content/10/1/12the activation capacity of human sperm by microinjection
into mouse oocytes [3,134,136]. This assay represents a
useful method with which to investigate cases of low ICSI
success rates [106]. However, considering that human
PLCζ is thought to be more potent in its activity com-
pared to mouse PLCζ [33], and that oocytes from various
species are thought to be ‘fine-tuned’ to specific levels and
activity of PLCζ from that species [64], it is possible that
the MOAT may only be useful to detect extreme cases of
OAD where sperm is completely devoid of PLCζ, and not
cases where only a more subtle reduction is evident. Of
course, such tests require the provision of animal facilities
and specialised skills which may not be routinely availablefor most ART centres, and may therefore be more useful
in a research setting.
Identifying a pattern of localisation of PLCζ that is
compatible with its role as the putative endogenous oo-
cyte activation factor provides further confirmation of its
physiological relevance as a mediator of this important
process. Moreover, the identification of specific localisa-
tion patterns in fertile males, and their precise functional
roles, would provide a key benchmark to which infertile
sperm may be compared. Previous work using immuno-
fluorescent techniques has already demonstrated that
there appears to be a pattern of PLCζ localisation in the
sperm head that is consistent with fertile sperm [86,106],
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[74,86,107], implicating a correlation between an abnor-
mal localisation pattern of PLCζ with aberrant function/
infertility. This suggests that by determining the expres-
sion, and localisation pattern, of PLCζ in sperm is likely
to represent a credible index of oocyte activation ability
for patients seeking ART.
Kashir et al. (2011b) investigated the effects of routine
ART techniques upon the levels of PLCζ in fertile male
donors, and revealed that cryopreservation, a common
technique utilised for the preservation of fertility in
patients undergoing fertility treatment as well as radio/
chemotherapy or surgery [151], had a significant detri-
mental effect upon the levels of PLCζ compared with
fresh sperm [152]. Furthermore, Nakai et al. (2011)
showed that the pre-treatment of pig sperm reduced oo-
cyte-activating ability via significant reductions in the
levels of PLCζ levels compared with untreated sperm
[110]. Interestingly, Nakai et al. (2011) also detected a
population of PLCζ in the tail of pig sperm. Removal of
the tail via pre-treatment methods reduced oocyte-acti-
vation ability, indicating that optimal ability was
achieved via ICSI using only whole sperm [110]. Given
that low PLCζ concentrations in sperm are linked with
infertility, these studies further support the notion that
PLCζ represents a beneficial biomarker for ART. Indeed,
Kashir et al. (2011b) demonstrated that density gradient
washing (DGW; a centrifugation method used to isolate
the best quality sperm based on motility parameters)
increased the proportion of sperm exhibiting PLCζ im-
munofluorescence in fertile male donors [152], thus in-
creasing the likelihood of successful activation.
Since PLCζ mRNA has been identified in sperm
[120,121], it is possible that the determination of PLCζ
mRNA may represent another useful clinical indicator,
although the precise function of this mRNA store is not
yet known. Several studies have already demonstrated
the differential expression of some key mRNAs in infer-
tile males compared to fertile males [122,147,153], thus
suggesting the potential for the development of a fertility
index via relative expression analysis. Indeed, Kaewmala
et al. (2011) indicated that higher levels of PLCζ mRNA
in boar sperm correlated with better quality [109], while
Aghajanpour et al. (2011) investigated whether the level
of PLCζ mRNA in human sperm may be an indicator of
the potential of a patient sample to induce oocyte activa-
tion [115]. The authors of the latter report identified a
significant reduction in levels of PLCζ mRNA in indivi-
duals with low or failed fertilisation with ICSI, compared
to fertile controls. It follows then that the relative ex-
pression of PLCζ mRNA may represent a credible bio-
marker of the oocyte activation ability of a given sperm
sample. Indeed, several authors hypothesise that the fu-
ture of male infertility diagnosis may rely heavily uponthe use of microarrays to determine the expression levels
of target mRNAs in discrete sperm samples [154-158].
Interestingly, a recent study revealed that by assessing
the rhythmical cytoplasmic movements triggered by Ca2+
oscillations in the fertilised mouse oocyte using particle
image velocimetry (PIV), it was possible to predict the de-
velopmental potential of the zygote [159], thus offering a
potential viability index for oocytes fertilised in-vitro.
Swann et al. (2012) further validated the concept of PIV
analysis by demonstrating that the frequency of PLCζ-
induced cytoplasmic Ca2+ oscillations and the pattern of
cytoplasmic movements within aged ICSI-failed human
oocytes were synchronous in nature [160]. Collectively,
these studies indicate that the use of PIV to analyse cyto-
plasmic movements may represent an exciting non-inva-
sive method for monitoring Ca2+ oscillation patterns in
human oocytes in a clinical setting, thereby providing an
early and effective indicator of zygote viability following
IVF [159,160].
Increasing evidence supports the importance of oocyte
factors in the fertilising potential of an oocyte. The oo-
cyte undergoes cellular arrangement and modifications
during maturation to optimise the internal environment
for optimal Ca2+ release ability upon sperm fusion [128].
A dysfunctional environment within the oocyte, in the
case of an aged oocyte for example, is very likely to im-
pede the process of fertilisation [161]. Further under-
standing of the factors and mechanisms involved in
creating a fully viable oocyte are equally as important as
understanding the manner in which the fertilising sperm
induces Ca2+ release upon gamete fusion. Important les-
sons can be gained via expression studies in the labora-
tory; for example, studies demonstrating successful Ca2+
release upon the expression of recombinant PLCζ in one
specific cell line but not another cell type [74,93], indi-
cate that there may be hitherto unknown oocyte compo-
nents that are required for the activation process.
Elucidation of the specific identities of such factors may
explain how PLCζ is maintained in an inactive state in
the sperm but activated upon release into the oocyte.
Furthermore, evidence suggests that in addition to inter-
action with oocyte factors, PLCζ may undergo post-
translational modifications before attaining the ability to
induce Ca2+ release. Cooney et al. (2010) suggest that
this is a key requirement for PLCζ to attain endogenous
activity [64,74,162]. It is important that future studies
aim to confirm whether post-translational modifications
and/or proteolytic cleavage, are important for the func-
tional role of PLCζ, and address how deficiencies in
these processes may relate to an infertile state.
Conclusions
It is clear that PLCζ plays a fundamental role in the activa-
tion of mammalian oocytes and that genetic, molecular or
Q1
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linked to OAD and human infertility. Consequently, there
is significant scope for our understanding of PLCζ to
be translated to the ARTclinic, both as a novel therapeutic
agent with which to rescue OAD, or as a prognostic/
diagnostic biomarker of oocyte activation ability in target
sperm samples. However, there are several key target areas
for future research that must be addressed. Firstly, al-
though an active recombinant human PLCζ protein has
been successfully synthesised in mammalian cell lysates
[74], steps must now be taken to extend such progress to
final purification, concentration, and activity testing. Such
work underpins the successful deployment of recombinant
PLCζ protein as a more physiological method of AOA
compared to current protocols. Secondly, there is signifi-
cant interest at present to identify novel biomarkers of
sperm function to complement and extend current semen
analysis procedures in the ART clinic. Initial findings indi-
cate that PLCζ represents a useful prognostic/diagnostic
biomarker of oocyte activation ability. However, several
questions remain to be addressed before PLCζ may be
competently utilised in this clinical capacity. For example,
we cannot yet confirm beyond doubt whether a specific
pattern of PLCζ localisation is required for successful oo-
cyte activation, or whether the mere presence of PLCζ
within a particular concentration window, regardless of lo-
calisation pattern, is all that is required. It is also necessary
to address the potential effects that routine ART laboratory
techniques may exert upon PLCζ concentration and func-
tion within human sperm, and whether such effects may
inadvertently reduce fertilisation capacity in a clinical set-
ting. It is imperative that future research adopts a range of
experimental approaches in the research laboratory, but
also allows for intensified screening within the clinical set-
ting, which includes cases related to OAD, ICSI-failure,
and idiopathic infertility. It is readily apparent that clinical
data relating to PLCζ is still lacking, and that our current
understanding is based on only a limited number of cases.
However, given appropriate levels of research attention, it
is already clear that PLCζ is likely to provide the ARTclinic
with significant improvements to prognostic and diagnostic
testing, and safer options for therapeutic intervention.Abbreviations
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